TriSalus Life Sciences, Inc. TLSI Derivative Gain Loss On Derivative Net
Derivative Gain Loss On Derivative Net at other companies
Other financials
Where this comes from
Reported directly by TriSalus Life Sciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:DerivativeGainLossOnDerivativeNet.
The official record: TriSalus Life Sciences, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about TriSalus Life Sciences, Inc.'s derivative gain loss on derivative net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is TriSalus Life Sciences, Inc.'s derivative gain loss on derivative net?
- TriSalus Life Sciences, Inc. (TLSI) reported derivative gain loss on derivative net of $3.9M in Q1 2026.
- How has TriSalus Life Sciences, Inc.'s derivative gain loss on derivative net changed year-over-year?
- TriSalus Life Sciences, Inc.'s derivative gain loss on derivative net increased by 567.1% year-over-year, from -$835K to $3.9M.
- What is the long-term trend for TriSalus Life Sciences, Inc.'s derivative gain loss on derivative net?
- Over 2 years (2022 to 2025), TriSalus Life Sciences, Inc.'s derivative gain loss on derivative net has grown at a 36.9% compound annual growth rate (CAGR), from -$2.19M to -$4.1M.
- What does derivative gain loss on derivative net mean?
- Represents the net non-cash gain or loss recognized from changes in the fair value of derivative financial instruments. This metric helps investors isolate market-driven valuation fluctuations from core operational performance. It is critical for assessing the impact of hedging activities or speculative financial positions on the bottom line.